SCHEMBL4124759

SCHEMBL4124759

COc1cccc(C(O)c2cc(OC(F)(F)F)ccc2N)c1OC

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
ATM Q13315 1/20 0.38
ADRA2A P08913 2/20 0.37
ADRA1A P35348 2/20 0.37
GRIN2B Q13224 2/20 0.37
CYP2D6 P10635 1/20 0.36
IGF1R P08069 1/20 0.36
RUNX1 Q01196 1/20 0.36
MAPK1 P28482 1/20 0.36
BLM P54132 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
GAA P10253 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4123660 0.84 TAS1R3 (0.38) ALDH1A1MAPTMEN1KMT2ACYP2D6
SCHEMBL13775821 0.83 MAPT (0.44) ALDH1A1MAPTMEN1KMT2AATM
SCHEMBL4119685 0.82 FDFT1 (0.37) ALDH1A1MAPTMEN1KMT2AATM
SCHEMBL4131102 0.82 FDFT1 (0.37) ALDH1A1MAPTMEN1KMT2AATM
SCHEMBL4116475 0.82 ALDH1A1 (0.44) ALDH1A1MAPTMEN1KMT2AATM
SCHEMBL4127954 0.80 NPC1 (0.41) ALDH1A1MAPTMEN1KMT2ANPC1
SCHEMBL4116675 0.80 ALDH1A1 (0.44) ALDH1A1MAPTMEN1KMT2AATM
SCHEMBL4109691 0.79 ALDH1A1 (0.43) ALDH1A1MAPTMEN1KMT2AATM
SCHEMBL4111096 0.79 ALDH1A1 (0.43) ALDH1A1MAPTMEN1KMT2AATM
SCHEMBL4679921 0.79 ALDH1A1 (0.43) ALDH1A1MAPTMEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR ALDH1A1 1587/4885MAPT 4428/4885MEN1 2041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.